Growth related oncogene-alpha (GRO-a): Roles in atherosclerosis, angiogenesis and other inflammatory conditions

Medical Science Monitor

Volumn 13, Issue 6, 2007, Pages

  Bechara, Carlos ^a   Chai, Hong ^a   Lin, Peter H ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Chemokine; Growth related oncogene alpha; Inflammation

Indexed keywords

ANGIOGENESIS; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENE FUNCTION; HUMAN; INFLAMMATION; LEUKOCYTE; MELANOMA CELL; ONCOGENE; ONCOGENE GRO ALPHA; PANCREAS CANCER; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINES, CXC; HUMANS; INFLAMMATION; LEUKOCYTES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34249808214     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Ross R: The pathogenesis of atherosclerosis- an update. N Engl J Med, 1986; 314: 488-500
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990"s. Nature, 1993; 362: 801-9
3. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation, 2004; 109: III27-32
4. Jonasson L, Holm J, Skalli O et al: Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis, 1986; 6: 131-38
5. Van Der Wal AC, Das PK, Bentz Van De Berg D et al: Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest, 1989; 61: 166-70
6. Raines EW, Rosenfeld ME, Ross R: The role of macrophages. In: Fuster V, Ross R, Topol EJ (eds.) Atherosclerosis and Coronary artery disease. Vol.1. Philedelphia: Lippincott-Raven, 1996: 539-55
7. Falk E, Shah PK, Fuster V: Pathogenesis of plaque disruption. In: Fuster V, Ross R, Topol EJ (eds.) Atherosclerosis and Coronary artery disease. Vol.2. Philedelphia: Lippincott-Raven, 1996; 492-510
8. Stary HC: The histological classification of atherosclerotic lesions in human coronary arteries. In: Fuster V, Ross R, Topol EJ (eds.) Atherosclerosis and Coronary artery disease. Vol.1. Philadelphia: Lippincott-Raven, 1996: 463-74
9. Zalokar JB, Richard JL, Claude JR: Leukocyte count, smoking, and myocardial infarction. N Engl J Med, 1981; 304: 465-508
10. Mohacsi A, Kozlovszky B, Kiss I et al: Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli. Biochim Biophys Acta, 1996; 1316: 210-16
11. Kougias P, Chai H, Lin PH et al: Neutrophil antimicrobial peptide a-defensin causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg, 2006; 43: 357-63
12. Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity, 2000; 12: 121-27
13. Middleton RK, Lloyd GM, Bown MJ et al: The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study. J Vasc Surg, 2007; 45: 574-80
14. Laurence M: Location, movement and survival: the role of chemokines in haemetopoiesis and malignancy. British J Haematology, 2005; 132: 255-67
15. Clark-lewis I, Schumacher C, Baggiolini M et al: Structure-activity relationships of interleukine-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem, 1991; 266: 23128-34
16. Strieter RM, Polverini PJ, Kunkel SL et al: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem, 1995; 270: 27348-57
17. Angiolillo AL, Sgadari C, Taub DD et al: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med, 1995; 182: 155-62
18. Rusconi S, Scozzafava A, Mastrolorenzo A et al: New advances in HIV entry inhibitors development. Curr Drug Targets Infect Disord, 2004; 4: 339-55
19. Anisowicz A, Bardwell L, Sager R: Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci USA, 1987; 84: 7188-92
20. Richmond A, Balentien E, Thomas HG et al: Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. Eur Mol Biol Organ J, 1988; 7: 2025-33
21. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 1994; 76: 301-14
22. Geiser T, Dewald B, Ehrengruber MU et al: The interleukine-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem, 1993; 268: 15419-24
23. Bozic CR, Kolakowski LF Jr, Gerard NP et al: Expression and biologic characterization of the murine chemokine KC. J Immunol, 1995; 154: 6048-57
24. Lira SA, Zalamea P, Heinrich JN et al: Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med, 1994; 180: 2039-48
25. Jinquan T, Frydenberg J, Mukaida N et al: Recombinant human growthregulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by INF-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol, 1995; 155: 5359-68
26. Walz A, Meloni F, Clark-Lewis I et al: (Ca2+)i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/ interleukine 8, NAP-2, and gro/MGSA. J Leukoc Biol, 1991; 50: 279-86
27. Schwartz D, Andalibi A, Chaverri-Almada L et al: Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest, 1994; 94: 1968-73
28. Boisvert WA, Santiago R, Curtiss LK et al: A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest, 1998; 101: 353-63
29. Weber KS, Von Hundelshausen P, Clark-Lewis I et al: Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol, 1999; 29: 700-12
30. Smith DF, Galkina E, Ley K et al: GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol, 2005; 289: H1976-84
31. Gerszten RE, Garcia-Zepeda EA, Lim YC et al: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 1999; 398: 718-23
32. Koch AE, Polverini PJ, Kunkel SL et al: Interleukin-8 as a macrophagederived mediator of angiogenesis. Science, 1992; 258: 1798-801
33. Caunt M, Hu L, Tang T et al: Growth-related oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res, 2006; 66: 4125-32
34. Owen JD, Streiter R, Burdick M et al: Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/ growth-related cytokine beta and gamma proteins. Int J Cancer, 1997; 73: 94-103
35. Luan J, Shattuck-Brandt R, Haghnegahdar H et al: Mechanism and biological significance of constituitive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol, 1997; 62: 588-97
36. Moore BB, Arenberg DA, Stoy K et al: Distinct CXC chemokines mediate tumorgenicity of prostate cancer cells. Am J Pathol, 1999; 154: 1503-12
37. Traves SL, Culpitt SV, Russell RE et al: Increased levels of the chemokines GRO alpha and MCP-1 in sputum samples from patients with COPD. Thorax, 2002; 57: 590-95
38. Issa R, Xie S, Lee KY et al: GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-KappaB and MAP kinases. Am J Physiol Lung Cell Mol Physiol, 2006; 291: L66-74
39. Koch AE, Kunkel SL, Shah MR et al: Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol, 1995; 155: 3660-66
40. Takamori H, Oades ZG, Hoch OC et al: Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas, 2000; 21: 52-56
41. Eck M, Schmausser B, Scheller K et al: Pleiotropic effects of CXC chemokines in gastric cancer: differences in CXCL8 and CXCL1 expression between diffuse and intestinal type of gastric carcinoma. Clin Exp Immunol, 2003; 134: 508-15
42. Fujisawa N, Hayashi S, Kurdowska A et al: Inhibition of GRO-alpha induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. Cytokine, 1999; 11: 231-38